Compound Detail
CHEMBL978
METHACHOLINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL978 |
| Name | METHACHOLINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | NZWOPGCLSHLLPA-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
6
Targets
11
Activities
3
Assay Types
0
PK Parameters
20
Publications
3
Known Names
1
Indications
Molecular Properties
160.2
MW (Da)
0.64
ALogP
2
HBA
0
HBD
26.3
PSA (Ų)
0.45
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1986 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Asthma
ATC Classification
V04CX03
methacholine
Level 1: VARIOUS
Level 2: DIAGNOSTIC AGENTS
Activity Summary
IC50 5 meas. best 6.42
Ki 4 meas. best 7.23
EC50 2 meas. best 6.92
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Muscarinic acetylcholine receptor M2 CHEMBL211 | Ki | 7.23 | 7.23 | 59.0 | 1 |
| Muscarinic acetylcholine receptor M2 CHEMBL309 | Ki | 7.23 | 7.23 | 59.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL320 | EC50 | 6.92 | 6.92 | 120.0 | 1 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | IC50 | 6.42 | 5.85 | 380.0 | 2 |
| Muscarinic acetylcholine receptor M2 CHEMBL309 | IC50 | 6.42 | 5.85 | 380.0 | 2 |
| Muscarinic acetylcholine receptor M1 CHEMBL276 | EC50 | 6.4 | 6.4 | 400.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL317 | IC50 | 6.16 | 6.16 | 700.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 5.8 | 5.8 | 1600.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL317 | Ki | 5.8 | 5.8 | 1600.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 9622546 | 10.1021/jm9705115 | Muscarinic acetylcholine receptor M2 | 6 |
| 9622546 | 10.1021/jm9705115 | Muscarinic acetylcholine receptor M3 | 3 |
| 9622546 | 10.1021/jm9705115 | Muscarinic acetylcholine receptor M4 | 3 |
| 9622546 | 10.1021/jm9705115 | Muscarinic acetylcholine receptor M1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 38318365 | 10.1016/j.isci.2024.108907 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 1 |
| 671450 | 10.1021/jm00204a007 | ADMET | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent dopamine transporter | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Estrogen receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Acetylcholinesterase | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent noradrenaline transporter | 1 |
| 20020916 | 10.1080/15376510701857262 | Phospholipidosis | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 1 |
| 16190743 | 10.1021/jm0503244 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine